Merial Introduces New Molecular Technology to PUREVAX® Recombinant FeLV Vaccine to Provide Improved Potency
January 15, 2012
Only non-adjuvanted feline leukemia vaccine to be available in convenient subcutaneous injectableDuluth, Ga. — Today at the North American Veterinary Conference (NAVC) in Orlando, Fla., Merial announced PUREVAX® Recombinant FeLV - the newest addition to the only non-adjuvanted line of feline vaccines in the U.S. Delivered subcutaneously, PUREVAX features improved potency, and has a lower antigen concentration than the previous PUREVAX Recombinant Leukemia Vaccine.1 It will be available in early spring 2012.
Feline leukemia virus (FeLV), while a contagious, lethal and incurable disease, is easily preventable through vaccination.2 FeLV causes cancer in about 20 percent of infected cats3 and contributes to other infectious diseases and anemia by suppressing the immune system and function of bone marrow.4 The American Association of Feline Practitioners (AAFP) recommends FeLV vaccination for all kittens,5 and an annual booster inoculation is recommended in cats considered to be at risk of exposure - namely those not housed strictly indoors.5
"PUREVAX Recombinant FeLV offers the convenience of subcutaneous delivery with the efficacy and safety you would expect from a non-adjuvanted recombinant vaccine," said Dr. Robert Menardi, marketing director for Pet Vaccines, Merial. "Non-adjuvanted vaccines may help reduce the potential risk of reactions caused by unnecessary proteins and adjuvants,6 including injection site reaction,7 injection site granuloma7 or chronic inflammation."7
®PUREVAX is a registered trademark of Merial. ©2012 Merial Limited, Duluth, GA. All rights reserved.
1Merial Data on File.
For further information please contact:
PUREVAX Recombinant FeLV is recommended for the vaccination of healthy cats 8 weeks or older as an aid in the prevention of disease due to feline leukemia virus. For primary vaccination, cats should receive two 1-ml dose vaccinations, three weeks apart. Annual booster injections are recommended in cats considered to be at risk of exposure. Diagnostic testing for FeLV prior to vaccination also is recommended.
Merial is a Sanofi company.